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Dear members and guests of our Society,
The Komrower lecture was founded by a gift from Mrs
Komrower and a bequest from Dr Komrower who died on
11 December 1989.
As is well known to many members of the Society, Dr
Komrower performed pioneering work in galactosaemia,
homocystinuria and he had a major impact in the early days
of newborn screening by introducing PKU screening in
Manchester in 1967.
You can find additional information about the life and
work of George Komrower in the introduction to the
Komrower lecture written by Brian Fowler and published in
the JIMD in 1993.
J. Inher. Metab. Dis. 16 (1993) 614–616
Introduction of the Komrower Commemorative
Lecture Dr Brian Fowler - Basel, March 1993
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I would now like to provide some background concerning
this years’ Komrower Memorial Lecturer: Prof. Bridget
Wilcken. The title of her lecture is “Newborn screening:
How are we travelling? Where might we get to?”
Bridget Wilcken knew Dr. Komrower personally, and I
hope that she will tell about the moments when they have
met. They shared research interests in homocystinuria as
well as in the new aspects of neonatal screening.
Bridget began her medical career in Edinburgh and
during her career she has worked at the Hammersmith and
Middlesex Hospitals in London, and spent time in the US,
before she went to Sydney, Australia.
From the late 1970s until 2008 she had an university
appointment as Clinical Professor in Paediatrics, Western
Clinical School, University of Sydney and was Clinical
Director of the New South Wales Biochemical Genetics
and Newborn Screening Services at The Children’s Hospi-
tal at Westmead, NSW, Australia.
The Newborn Screening Programme conducts tests on all
newborns in New South Wales and the Australian Capital
Territory for over 20 metabolic disorders and the Biochemical
Genetics Service investigates symptomatic patients from all of
NSW. These reference laboratories are the only in New South
Wales covering these fields.
She has been seeing metabolic patients at the Children’s
Hospital since 1984, and has gathered extensive experience
in metabolic medicine.
She retired in 2008 from both positions, and currently is
running a new adult metabolic service at the adjacent
Westmead Hospital.
Prof. Bridget Wilckens early research interests cen-
tred around investigations of Homocystinuria. Work linking
mild homocystinaemia to the occurrence of vascular disease
was carried out early on, and she has been prominently
involved in the introduction of betaine as a treatment in
pyridoxine-non-responsive cases of homocystinuria.
She also had an early interest in what was then a new
field: the fatty acid oxidation disorders, and she adopted
this area as a special interest of her laboratory. Her
pioneering studies included the first demonstration of the
neonatal presentation of fatty acid oxidation disorders, and
establishing a link between hepatic pathology in pregnancy
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associated to a fetus affected by long-chain 3-hydroxy-
acylCoA dehydrogenase deficiency.
And finally: Neonatal screening. In 1981 she was
responsible for the introduction in New South Wales of a
newborn screening programme for cystic fibrosis and she has
an extensive world-wide experience in this area. From the
first, this has been a very controversial topic, as firm evidence
for benefit from very early diagnosis was lacking. She
conducted a study of the efficacy of case-finding by screening,
the time and manner of diagnosis before screening, and
demonstrated improvement in morbidity and growth in
children identified by neonatal screening. This work greatly
impacted and enhanced the expansion of CF screening
throughout Australia, and in other parts of the world.
She started an exciting new direction in newborn
screening using Tandem mass spectrometry in 1998,
being the first publicly funded screening programme to
adopt this new screening technology. She was the chief
investigator in an Australia-wide study evaluating the
reliability, clinical outcomes and economics of tandem
mass spectrometry in newborn screening which was
reported in the New England Journal of Medicine.
MEMBERSHIP OF LEARNED SOCIETIES
Bridget was the President of the Human Genetics
Society of Australasia (HGSA) from 1997–1999.
She was a founding member of the Australasian Society
for Inborn Errors of Metabolism and became president in
1990. The society hosted the IXth International Congress of
Inborn Errors of Metabolism (ICIEM) in 2003 in Brisbane,
and she was the president of this meeting.
She was a founding member of the International Society
for Neonatal Screening in 1988, and in 1991, she was the
Chairman of the Organising Committee for the Eighth
International Screening Symposium, held in Sydney.
She has been Corresponding Member to the SSIEM
Council for many years.
AWARDS, PRIZES
In 2002 she was awarded the Order of Australia for
services to newborn screening. In 2004 she received the
Guthrie Medal from the International Society for Neonatal
Screening and in 2005 she was appointed to an Honorary
Fellowship of the Royal College of Pathologists of
Australia.
In summary she has been an advocate for patients for a
number of years, as physician, laboratory investigator and
political activist, and yet has been able to maintain a very
productive research career, with over 140 publications and
8 book chapters.
When I asked her how she looks back to her career
she wrote me: I quote
“What I think I should like realised is that I haven’t
worked all this time. I had virtually 11 years spent
largely raising a family, (1960 to 1971) which nobody
would do nowadays, and then worked part-time for
about 12 years, so my training and experience have
been quite spotty. I “retired” in 2008, since when
other people’s events have conspired to keep me
working. And I completed a doctorate only in 2009.
So it has been an odd career”.
Cornelis Jakobs, September 2010
Chairman SSIEM
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